CN109453285A - A kind of Chinese medicine for treating cervical vertebra hyperplasia - Google Patents
A kind of Chinese medicine for treating cervical vertebra hyperplasia Download PDFInfo
- Publication number
- CN109453285A CN109453285A CN201811633688.1A CN201811633688A CN109453285A CN 109453285 A CN109453285 A CN 109453285A CN 201811633688 A CN201811633688 A CN 201811633688A CN 109453285 A CN109453285 A CN 109453285A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cervical vertebra
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
A kind of a kind of Chinese medicine composition, and in particular to Chinese medicine for treating cervical vertebra hyperplasia.The Chinese medicine includes following raw material: 15~28 parts of Radix Codonopsis, 35~50 parts of Radix Salviae Miltiorrhizae, 8~24 parts of pueraria lobata, 10~30 parts of Rhizoma Chuanxiong, 15~25 parts of eupolyphage sece steleophaga, 10~25 parts of first pearl, 12~26 parts of Divine Comedy, 16~25 parts of Radix Paeoniae Alba, 18~23 parts of Radix Astragali, 15~28 parts of pheretima, 15~25 parts of peach kernel, 33~46 parts of dragon's blood, 13~27 parts of rhizoma cyperi, 17~26 parts of safflower, 30~50 parts of Radix Notoginseng, 45~60 parts of rhizoma dioscoreae nipponicae, 35~55 parts of lopseed and 25~35 parts of ramulus cinnamomi.Each traditional Chinese medicinal components provided by the invention are conventional constituents, and all raw materials can voluntarily be bought, and are voluntarily prepared convenient for patient, meanwhile, the Chinese medicine is pulvis, oral solution or pill.
Description
Technical field
The present invention relates to a kind of Chinese medicine compositions, and in particular to a kind of Chinese medicine for treating cervical vertebra hyperplasia.
Background technique
Cervical vertebra hyperplasia refers to the retrogression pathological changes of cervical intervertebral disk and the disease of osteoproliferation compressing cervical spinal cord or cervical nerve root
Suffer from, also known as cervical syndrome, Chinese medicine category heumatism, chronic strain scope.As the different phase at age develops, cervical vertebra and interverbebral disc
Different changes can occur, while degenerative change occurs for body of cervical vertebra, interverbebral disc also occurs accordingly to change.
Currently, mostly using drug therapy for cervical vertebra hyperplasia, and the overwhelming majority is treated using Western medicine, Western medicine can be fast
Speed alleviates the feeling of pain of cervical vertebra hyperplasia, but there are repeatabilities, cannot be from basic the problem for the treatment of cervical vertebra hyperplasia.
Summary of the invention
For the deficiency of western medicine cervical vertebra hyperplasia, the present invention provides a kind of Chinese medicine for treating cervical vertebra hyperplasia and its preparation side
Method, this method can not only overcome the shortcomings of Western medicine, also have better therapeutic effect.
The present invention is composed of the following raw materials by weight: 15~28 parts of Radix Codonopsis, 35~50 parts of Radix Salviae Miltiorrhizae, 8~24 parts of pueraria lobata, Rhizoma Chuanxiong
10~30 parts, 15~25 parts of eupolyphage sece steleophaga, 10~25 parts of first pearl, 12~26 parts of Divine Comedy, 16~25 parts of Radix Paeoniae Alba, 18~23 parts of Radix Astragali,
Dragon 15~28 parts, 15~25 parts of peach kernel, 33~46 parts of dragon's blood, 13~27 parts of rhizoma cyperi, 17~26 parts of safflower, 30~50 parts of Radix Notoginseng,
45~60 parts of rhizoma dioscoreae nipponicae, 35~55 parts of lopseed and 25~35 parts of ramulus cinnamomi.
Preferably, the invention raw material is as follows: 22 parts of Radix Codonopsis, 46 parts of Radix Salviae Miltiorrhizae, 18 parts of pueraria lobata, 20 parts of Rhizoma Chuanxiong, eupolyphage sece steleophaga
20 parts, 18 parts of first pearl, 24 parts of Divine Comedy, 23 parts of Radix Paeoniae Alba, 18 parts of Radix Astragali, 19 parts of pheretima, 25 parts of peach kernel, 40 parts of dragon's blood, 25 parts of rhizoma cyperi,
21 parts of safflower, 36 parts of Radix Notoginseng, 55 parts of rhizoma dioscoreae nipponicae, 47 parts of lopseed and 32 parts of ramulus cinnamomi.
The Chinese medicine of above-mentioned treatment cervical vertebra hyperplasia disease, be prepared into according to conventional Chinese drug preparation technique oral solution or pulvis or
Pill.
The present invention is according to following principle:
Radix Codonopsis: have the effects that strengthen immunity, expansion blood vessel, decompression, improve microcirculation, enhancing hematopoiesis function.Furthermore
There is castering action to the decline of leucocyte caused by chemotherapy radiotherapy.
Radix Salviae Miltiorrhizae: this kind of root is used as medicine, and contains tanshinone, is robustness emmenagogue, there is the effectiveness such as dissolving stasis, raw new, promoting blood circulation, menstruation regulating.
Pueraria lobata: having expelling pathogenic factors from muscles and skin to bring down a fever, and promoting eruption promotes the production of body fluid to quench thirst, the function of Shengyang Zhixie, is usually used in exterior syndrome fever, stiff nape and back, fiber crops
Rash is impermeable, and pyreticosis is thirsty, and the deficiency of Yin is quenched one's thirst, and heat is purged heat dysentery, splenasthenic diarrhea.
Eupolyphage sece steleophaga: dissipating blood stasis with potent drugs, reunion of fractured tendons and bones cure mainly blood stasis, and abdominal mass block is beaten the stasis of blood swell, and muscles and bones fracture is suitable for the stasis of blood
Blood blocks various illnesss.
First pearl: cream, anti-stain in solid under blood circulation promoting and dispersing pathogen accumulation, promoting menstruation.
Radix Astragali: enhancing body's immunity, liver protection, diuresis, anti-aging, resisting stress, decompression and wide antibacterial make
With.
Pheretima: heat-clearing, relieve the wind syndrome, relieving asthma, dredging collateral, diuresis effect.
Peach kernel, safflower: both there is promoting blood circulation effect, be often used cooperatively.
Rhizoma dioscoreae nipponicae: dispelling wind and eliminating dampness, promoting blood circulation and removing obstruction in channels, cough-relieving, before main rheumatism numbness, carbuncle swells.
Lopseed: dispelling wind and eliminating dampness, relaxing tendons and activating collaterals, promoting blood circulation and stopping pain.
The invention has the following advantages:
(1) each traditional Chinese medicinal components provided by the invention are unlimited determines production method, and pulvis, oral solution or pill will not influence medicine
Effect, each comparison of ingredients are stablized；
(2) each traditional Chinese medicinal components provided by the invention are conventional constituents, and all raw materials can voluntarily be bought, and are convenient for patient
Voluntarily prepare.
Specific embodiment
It elaborates below with reference to embodiment to the present invention.
Embodiment 1
15 parts of Radix Codonopsis, 35 parts of Radix Salviae Miltiorrhizae, 8 parts of pueraria lobata, 10 parts of Rhizoma Chuanxiong, 15 parts of eupolyphage sece steleophaga, 10 parts of first pearl, 12 parts of Divine Comedy, Radix Paeoniae Alba 16
Part, 18 parts of Radix Astragali, 28 parts of pheretima, 25 parts of peach kernel, 46 parts of dragon's blood, 27 parts of rhizoma cyperi, 26 parts of safflower, 50 parts of Radix Notoginseng, 60 parts of rhizoma dioscoreae nipponicae,
55 parts and 35 parts of ramulus cinnamomi of lopseed.Oral solution is prepared into according to conventional Chinese drug preparation technique.
Embodiment 2
15 parts of Radix Codonopsis, 35 parts of Radix Salviae Miltiorrhizae, 8 parts of pueraria lobata, 10 parts of Rhizoma Chuanxiong, 15 parts of eupolyphage sece steleophaga, 10 parts of first pearl, 12 parts of Divine Comedy, Radix Paeoniae Alba 16
Part, 18 parts of Radix Astragali, 28 parts of pheretima, 25 parts of peach kernel, 46 parts of dragon's blood, 27 parts of rhizoma cyperi, 26 parts of safflower, 50 parts of Radix Notoginseng, 60 parts of rhizoma dioscoreae nipponicae,
55 parts and 35 parts of ramulus cinnamomi of lopseed.Pulvis is prepared into according to conventional Chinese drug preparation technique.
Embodiment 3
15 parts of Radix Codonopsis, 35 parts of Radix Salviae Miltiorrhizae, 8 parts of pueraria lobata, 10 parts of Rhizoma Chuanxiong, 15 parts of eupolyphage sece steleophaga, 10 parts of first pearl, 12 parts of Divine Comedy, Radix Paeoniae Alba 16
Part, 18 parts of Radix Astragali, 28 parts of pheretima, 25 parts of peach kernel, 46 parts of dragon's blood, 27 parts of rhizoma cyperi, 26 parts of safflower, 50 parts of Radix Notoginseng, 60 parts of rhizoma dioscoreae nipponicae,
55 parts and 35 parts of ramulus cinnamomi of lopseed.Pill is prepared into according to conventional Chinese drug preparation technique.
Embodiment 4
28 parts of Radix Codonopsis, 50 parts of Radix Salviae Miltiorrhizae, 24 parts of pueraria lobata, 30 parts of Rhizoma Chuanxiong, 25 parts of eupolyphage sece steleophaga, 25 parts of first pearl, 26 parts of Divine Comedy, Radix Paeoniae Alba 25
Part, 23 parts of Radix Astragali, 15 parts of pheretima, 15 parts of peach kernel, 33 parts of dragon's blood, 13 parts of rhizoma cyperi, 17 parts of safflower, 30 parts of Radix Notoginseng, 45 parts of rhizoma dioscoreae nipponicae,
35 parts and 25 parts of ramulus cinnamomi of lopseed.Pill is prepared into according to conventional Chinese drug preparation technique.
Embodiment 5
22 parts of Radix Codonopsis, 46 parts of Radix Salviae Miltiorrhizae, 18 parts of pueraria lobata, 20 parts of Rhizoma Chuanxiong, 20 parts of eupolyphage sece steleophaga, 18 parts of first pearl, 24 parts of Divine Comedy, Radix Paeoniae Alba 23
Part, 18 parts of Radix Astragali, 19 parts of pheretima, 25 parts of peach kernel, 40 parts of dragon's blood, 25 parts of rhizoma cyperi, 21 parts of safflower, 36 parts of Radix Notoginseng, 55 parts of rhizoma dioscoreae nipponicae,
47 parts and 32 parts of ramulus cinnamomi of lopseed.Pill is prepared into according to conventional Chinese drug preparation technique.
Embodiment 6
The addition number of lopseed is 0, and the number of remaining each raw material is identical with embodiment 5.
Embodiment 7
The addition number of rhizoma dioscoreae nipponicae is 0, and the number of remaining each raw material is identical with embodiment 5.
Embodiment 8
The addition number of eupolyphage sece steleophaga is 0, and the number of remaining each raw material is identical with embodiment 5.
Above-described embodiment is only intended to citing and explanation of the invention, and is not intended to invent and is limited to described reality
Within the scope of applying.Furthermore it will be appreciated by persons skilled in the art that the present invention is not limited to the above embodiment, according to the present invention
Introduction can also make more kinds of variants and modifications, these variants and modifications all fall within scope of the present invention
It is interior.
16 ages volunteer similar in 40~50 one full year of life, cervical vertebra hyperplasia degree is selected, 8 group # 1~8 are divided into,
Wherein No. 1 group takes the drug of the preparation of embodiment 1, No. 2 groups take the drug of the preparation of embodiment 2, No. 3 groups take the system of embodiment 3
Standby drug, No. 4 groups take the drug of the preparation of embodiment 4, No. 5 groups take the drug of the preparation of embodiment 5, No. 6 groups take implementation
The drug of the preparation of example 6, No. 7 groups take the drug of the preparation of embodiment 7, No. 8 groups take drug prepared by embodiment 8.
16 ages volunteer similar in 50~60 one full year of life, cervical vertebra hyperplasia degree is selected, 8 group # 9~16 are divided into,
Wherein No. 9 groups take embodiment 1 preparation drug, wherein No. 10 groups take embodiment 2 preparation drug, wherein No. 11 groups are taken
Embodiment 3 prepare drug, wherein No. 12 groups take embodiment 4 preparation drug, wherein No. 13 groups take embodiment 5 preparation
Drug, wherein No. 14 groups take embodiment 6 preparation drug, wherein No. 15 groups take embodiment 7 preparation drug, wherein No. 16
Group takes the drug of the preparation of embodiment 8.
Daily three times, Time of Administration is 3 months to drug fixed weight prepared by the present invention to each group volunteer, and at this
Other drugs are not taken in three months.
The Cure of each group volunteer is as shown in table 1:
1 cervical vertebra hyperplasia therapeutic effect of table
According to above-described embodiment it is found that Chinese medicine production method of the present invention will not influence drug effect, for cervical vertebra hyperplasia
Cure rate be 85%, symptom mitigation rate be 100%.
Claims (3)
1. a kind of Chinese medicine for treating cervical vertebra hyperplasia, which is characterized in that including following raw material: 15~28 parts of Radix Codonopsis, Radix Salviae Miltiorrhizae
35~50 parts, 8~24 parts of pueraria lobata, 10~30 parts of Rhizoma Chuanxiong, 15~25 parts of eupolyphage sece steleophaga, 10~25 parts of first pearl, 12~26 parts of Divine Comedy, Radix Paeoniae Alba
16~25 parts, it is 18~23 parts of Radix Astragali, 15~28 parts of pheretima, 15~25 parts of peach kernel, 33~46 parts of dragon's blood, 13~27 parts of rhizoma cyperi, red
Spend 17~26 parts, 30~50 parts of Radix Notoginseng, 45~60 parts of rhizoma dioscoreae nipponicae, 35~55 parts of lopseed and 25~35 parts of ramulus cinnamomi.
2. a kind of Chinese medicine for treating cervical vertebra hyperplasia according to claim 1, which is characterized in that each raw material are as follows: party
Join 22 parts, 46 parts of Radix Salviae Miltiorrhizae, 18 parts of pueraria lobata, 20 parts of Rhizoma Chuanxiong, 20 parts of eupolyphage sece steleophaga, 18 parts of first pearl, 24 parts of Divine Comedy, 23 parts of Radix Paeoniae Alba, Radix Astragali 18
Part, 19 parts of pheretima, 25 parts of peach kernel, 40 parts of dragon's blood, 25 parts of rhizoma cyperi, 21 parts of safflower, 36 parts of Radix Notoginseng, 55 parts of rhizoma dioscoreae nipponicae, lopseed 47
Part and 32 parts of ramulus cinnamomi.
3. a kind of Chinese medicine for treating cervical vertebra hyperplasia according to claim 1 or 2, which is characterized in that the Chinese medicine is mouth
Take one of liquid, pulvis or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811633688.1A CN109453285A (en) | 2018-12-29 | 2018-12-29 | A kind of Chinese medicine for treating cervical vertebra hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811633688.1A CN109453285A (en) | 2018-12-29 | 2018-12-29 | A kind of Chinese medicine for treating cervical vertebra hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109453285A true CN109453285A (en) | 2019-03-12 |
Family
ID=65615440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811633688.1A Pending CN109453285A (en) | 2018-12-29 | 2018-12-29 | A kind of Chinese medicine for treating cervical vertebra hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109453285A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600414A (en) * | 2012-03-07 | 2012-07-25 | 石晓英 | Chinese medicinal composition for treating cervical spondylosis |
| CN103893702A (en) * | 2014-04-15 | 2014-07-02 | 韩世昌 | Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof |
| CN107596053A (en) * | 2017-09-18 | 2018-01-19 | 成都赐绿源医药科技有限责任公司 | A kind of Chinese medicine composition and preparation method for treating aching pain in shoulder and back caused by cervical spondylopathy |
-
2018
- 2018-12-29 CN CN201811633688.1A patent/CN109453285A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600414A (en) * | 2012-03-07 | 2012-07-25 | 石晓英 | Chinese medicinal composition for treating cervical spondylosis |
| CN103893702A (en) * | 2014-04-15 | 2014-07-02 | 韩世昌 | Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof |
| CN107596053A (en) * | 2017-09-18 | 2018-01-19 | 成都赐绿源医药科技有限责任公司 | A kind of Chinese medicine composition and preparation method for treating aching pain in shoulder and back caused by cervical spondylopathy |
Non-Patent Citations (3)
| Title |
|---|
| 吴海忠等: ""中药配合推拿治疗颈椎病43例"", 《广西中医学院学报》 * |
| 谢艳等: "《骨伤科偏方验方精编》", 30 September 2017, 郑州大学出版社 * |
| 马汴梁: "《农家药采集加工与应用》", 31 March 2012, 金盾出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579774B (en) | Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes | |
| CN106540230A (en) | It is a kind of for alleviating quintessence oils of disease such as cervical spondylosiss, lumbar spondylosiss and preparation method thereof | |
| CN103961424A (en) | Traditional Chinese medicine formula for treating cervical spondylosis and preparation method of traditional Chinese medicine capsule preparation | |
| CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
| CN104491291A (en) | Traditional Chinese medicine composition for treating liver-yang hyperactivity type thyroid adenoma | |
| CN104147388B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
| CN105435128A (en) | Pill for treating liver qi stagnation and preparation method | |
| CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
| CN103585414B (en) | Pharmaceutical composition for treating sciatica and osteoporosis | |
| CN109453285A (en) | A kind of Chinese medicine for treating cervical vertebra hyperplasia | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN103720973A (en) | Chinese herbal medicine for treating lumbar disc herniation and preparation method thereof | |
| CN104547553A (en) | Traditional Chinese medicine for treating nervous endocrine disorder | |
| CN104225282A (en) | Traditional Chinese medicine for treating postpartum headache | |
| CN104706780A (en) | Traditional Chinese medicine decoction for treating intercostal neuralgia | |
| CN103638474B (en) | A kind of Chinese medicine for the treatment of atrophic gastritis | |
| CN100434103C (en) | Chinese medicine composition for treating anemogenous-ache disease | |
| CN103720972B (en) | Traditional Chinese herbal medicinal ointment for treating hyperostosis and preparation method thereof | |
| CN107737305B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN106474325A (en) | A kind of Chinese medicine preparation for treating cervical spondylopathy and waist dish outstanding and preparation method thereof | |
| CN105816603A (en) | Traditional Chinese medicine composition for treating postpartum hemorrhage | |
| CN104435704A (en) | Traditional Chinese medicine tablets for treating takayasu arteritis | |
| CN106138603A (en) | A kind of invigorating the kidney and strengthening the bones wine and preparation method thereof | |
| CN105327157A (en) | Traditional Chinese medicine for treating cerebrovascular blockage and preparation method thereof | |
| CN105326949A (en) | Traditional Chinese medicine for treating cardiovascular blockage and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190312 |
|
| RJ01 | Rejection of invention patent application after publication |